ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
injector pen ozempic wegovy
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com